| 000 | 01903 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515201722.0 | ||
| 264 | 0 | _c20100222 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1524-4563 | ||
| 024 | 7 |
_a10.1161/HYPERTENSIONAHA.109.145037 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoltzer, Els | |
| 245 | 0 | 0 |
_aEffects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cFeb 2010 |
||
| 300 |
_a516-22 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
| 650 | 0 | 4 |
_aAngiotensin III _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta, Abdominal _xdrug effects |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aIliac Artery _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aIrbesartan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 2 _xmetabolism |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aVerkuil, Anna V A | |
| 700 | 1 | _avan Veghel, Richard | |
| 700 | 1 | _aDanser, A H Jan | |
| 700 | 1 | _avan Esch, Joep H M | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 55 _gno. 2 _gp. 516-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/HYPERTENSIONAHA.109.145037 _zAvailable from publisher's website |
| 999 |
_c19407489 _d19407489 |
||